Girindus America, Inc. Appoints Dr. Edward Huber as Director - Analytical Development and Quality Control

31-May-2010 - USA

Girindus announced the appointment of Dr. Edward Huber as Director - Analytical Development & QC.

Dr. Huber will provide managerial and technical leadership in the areas of analytical development and quality control. He brings to Girindus 30 years of pharmaceutical experience in the area of structural elucidation, separations sciences, and the development and validation of analytical methods for the characterization and control of Active Pharmaceutical Ingredients (API) and finished dosage forms.

Dr. Huber received a BS degree from Xavier University and MS and PhD Degrees in Analytical Chemistry from the University of Cincinnati. Ed has demonstrated leadership qualities in both industry and the chemical community. Dr. Huber has held positions of increasing responsibility in analytical chemistry at Marion Merrell Dow, Hoechst Marion Roussel, Aventis and Patheon. He was most recently Director of Analytical Development within Patheon's Pharmaceutical Development Services group.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances